Key Market Indicators
**Korean Vaccination Coverage Steady at 98% for Children Aged 1 by 2028** South Korea's vaccination coverage for children aged one year old is projected to remain stable at 98% by 2028, unchanged from the current rate in 2023. This consistent coverage rate has been observed since 2005, indicating a stable market. **Stable Vaccination Rates at 99% for South Korean Infants** In 2023, the vaccination coverage for one-year-old children in South Korea remained at 99%, the same as in 2022. This figure has shown no year-on-year change, maintaining a steady pattern since 1986 with an annual growth of 0.2 percentage points. **South Korea's Vaccine Imports Projected to Rise** South Korea's vaccine imports are expected to reach approximately $316 million by 2028, up from $303 million in 2023. This marks an average annual growth rate of 0.5% since 1993, during which period the demand for vaccines has grown by 2.1% per year. **Korean Vaccine Exports to Hit $183 Million by 2028** The country's vaccine exports are forecasted to increase to about $184 million by 2028 from $179 million in 2023, reflecting a compound annual growth rate (CAGR) of 0.3%. Since 1993, South Korea's vaccine supply has risen by 1.5% annually. In 2023, South Korea ranked 14th in vaccine exports, with Austria slightly ahead at the same $179 million mark. Belgium, the United Kingdom, and France were the second, third, and fourth largest vaccine exporters, respectively.
